Target intelligence / Profile preview

Spectrin repeat containing nuclear envelope protein 1 (Nesprin-1 (also SYNE1))

Target
Nesprin-1 (also SYNE1)
Molecular classification
Scaffolding protein, Nuclear envelope protein, Spectrin-repeat protein, Member of the LINC complex (Linker of Nucleoskeleton and Cytoskeleton)
01

Overview

Nesprin-1 (spectrin repeat containing nuclear envelope protein 1) is a giant, multi-isomeric protein located primarily at the outer nuclear membrane, functioning as a scaffolding and structural link between the cytoskeleton and the nuclear envelope. It is a component of the LINC complex, which coordinates nuclear positioning, integrity, and mechanical signaling. Nesprin-1 is ubiquitously expressed, with various tissue-specific isoforms generated via alternative splicing. Mutations in the SYNE1 gene are associated with autosomal recessive cerebellar ataxia and muscular dystrophies, with increasing evidence for distinct roles in muscle and neuronal function. Research suggests isoform-specific disruption may contribute to disease phenotypes such as nuclear mispositioning and altered cell morphology. As of now, Nesprin-1 is not a direct pharmacological or therapeutic target, but it is important in understanding the molecular basis of several inherited diseases

Other names
Nesprin-1SYNE1Synaptic nuclear envelope protein 1
02

Biological functions

Maintains nuclear spatial organizationConnects cytoskeleton to nuclear envelopeFacilitates nuclear movement and positioningMechanical force transmission across the nuclear envelopeNuclear-cytoplasmic interactionsNuclear remodeling in spermatogenesis
03

Disease associations

Cerebellar ataxia (autosomal recessive spinocerebellar ataxia 8)Emery–Dreifuss muscular dystrophy (type 4)Dilated cardiomyopathyPotential roles in cancer (isoforms may be downregulated)
04

Biomarkers

Downregulation or mutation of Nesprin-1 isoforms may serve as a marker for some myopathies and possibly certain cancers, but these are not validated clinical biomarkers

Beyond the preview

Go deeper on Spectrin repeat containing nuclear envelope protein 1 (Nesprin-1 (also SYNE1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spectrin repeat containing nuclear envelope protein 1 (Nesprin-1 (also SYNE1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call